Mankind Pharma flags condom price hike as West Asia conflict lifts petroleum-linked input costs
India's condom market leader Manforce, with ~30% share, may raise prices on its Rs 100-150 per 10-pack range if oil stays above $100/barrel. Petroleum-derived inputs and latex sourcing through Malaysia's Karex are squeezing margins. Mankind also launched a generic semaglutide shot at Rs 1,300 to undercut tirzepatide priced up to Rs 27,000.
What happened
Mankind Pharma, India's condom market leader with ~30% share via Manforce, may hike prices if West Asia conflict keeps oil elevated, raising petroleum-linked
Key facts
- 30% market share
- Rs 100-150 per 10-pack
- oil above $100/barrel
- semaglutide at Rs 1,300
- tirzepatide up to Rs 27,000
Why this matters
Watch for tighter Mankind-Karex sourcing ties or backward integration into latex/petroleum derivatives, and scout generic GLP-1 partners as semaglutide pricing collapses the obesity-drug TAM.